Status
Conditions
Treatments
About
PLATA aims to develop an algorithm to identify vocal biomarkers of Alzheimer's dementia.
Using data collected as part of routine care, speech patterns will be compared to known biomarkers of Alzheimer's disease, such as amyloid 1-42 and p-Tau in CSF (cerebrospinal fluid).
If biomarkers of speech can be identified in Alzheimer's disease, it is possible that patients and research participants will no longer need to undergo need to undergo the intensive and invasive baseline biomarker methods currently used, such as lumbar punctures and PET scans.
Enrollment
Sex
Ages
Volunteers
Inclusion criteria
Exclusion criteria
100 participants in 1 patient group
Loading...
Central trial contact
Eric ETTORE, MD
Data sourced from clinicaltrials.gov
Clinical trials
Research sites
Resources
Legal